Sell
Jazz Pharmaceuticals (JAZZ) and Web.com Group (WWWW)
from US Investment Report. JAZZ was recommended at $59 in the March 18, 2013, Daily Alert and Investment Digest issue 739. WWWW was recommended at $17 in the February 25, 2013, Daily Alert and issue 738.
Stop-Loss Sales. During the past week, several of our model stocks that had been knocked down close to their stops in late September and early October were tipped below our stop-loss limits. None was a big loser, but among them were some stocks that had done very well for us before the current craziness in Washington began.
In the Growth Leaders Portfolio, we lost Jazz Pharmaceuticals (JAZZ) and [in] the Emerging Growth Portfolio we lost Web.com Group (WWWW).
Stephen Quickel, US Investment Report, www.usinvestmentreport.com, 215-862-0399, October 14, 2013